Cargando…
Endocrine and Metabolic Disorders after Hematopoietic Cell Transplantation
Chemotherapy treatment and autologous and allogeneic cell transplantations are often complicated by the onset of metabolic and endocrine disorders. Autoimmune disorders, metabolic diseases, and hormonal dysfunctions are some of the endocrine complications observed during or after treatment with immu...
Autor principal: | Paviglianiti, Annalisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236409/ https://www.ncbi.nlm.nih.gov/pubmed/31876135 http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0248 |
Ejemplares similares
-
Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study
por: Mima, Akira, et al.
Publicado: (2019) -
Diagnosis: Melanoderma after Hematopoietic Stem Cell Transplantation
por: Ünal, Şule, et al.
Publicado: (2015) -
Addition of venetoclax to myeloablative conditioning regimens for allogeneic hematopoietic stem cell transplantation in high-risk AML
por: Cao, Xing-yu, et al.
Publicado: (2023) -
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
por: Biavasco, Francesca, et al.
Publicado: (2022) -
Comparison of anti-thymocyte globulin-based immunosuppressive therapy and allogeneic hematopoietic stem cell transplantation in patients with transfusion-dependent non-severe aplastic anaemia: a retrospective study from a single centre
por: Shen, Yingying, et al.
Publicado: (2023)